🇺🇸 FDA
Pipeline program

A study to investigate the pharmacokinetics and safety of a single dose of duvakitug in healthy adult participants

PKM23567

Phase 1 other active

Quick answer

A study to investigate the pharmacokinetics and safety of a single dose of duvakitug in healthy adult participants for Healthy Volunteers is a Phase 1 program (other) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Healthy Volunteers
Phase
Phase 1
Modality
other
Status
active

Clinical trials